Turner D - Search Results

1

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.

Brenner B, Routy JP, Quan Y, Moisi D, Oliveira M, Turner D, Wainberg MA; Co-Investigators of the Quebec Primary Infection Study. Brenner B, et al. Among authors: turner d. AIDS. 2004 Aug 20;18(12):1653-60. doi: 10.1097/01.aids.0000131377.28694.04. AIDS. 2004. PMID: 15280776

2

Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients.

Turner D, Brenner BG, Routy JP, Petrella M, Wainberg MA. Turner D, et al. New Microbiol. 2004 Apr;27(2 Suppl 1):31-9. New Microbiol. 2004. PMID: 15646062 Review.

3

HIV-1 drug resistance: can we overcome?

Brenner BG, Turner D, Wainberg MA. Brenner BG, et al. Among authors: turner d. Expert Opin Biol Ther. 2002 Oct;2(7):751-61. doi: 10.1517/14712598.2.7.751. Expert Opin Biol Ther. 2002. PMID: 12387674 Review.

4

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, Marlink RG, Schapiro J, Roger M, Wainberg MA. Brenner B, et al. Among authors: turner d. AIDS. 2003 Jan 3;17(1):F1-5. doi: 10.1097/00002030-200301030-00001. AIDS. 2003. PMID: 12478089

5

Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.

Turner D, Brenner B, Wainberg MA. Turner D, et al. J Antimicrob Chemother. 2004 Jan;53(1):53-7. doi: 10.1093/jac/dkh009. Epub 2003 Nov 25. J Antimicrob Chemother. 2004. PMID: 14645322 Review.

6

The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.

Turner D, Schapiro JM, Brenner BG, Wainberg MA. Turner D, et al. Antivir Ther. 2004 Jun;9(3):301-14. Antivir Ther. 2004. PMID: 15259893 Review.

7

Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.

Turner D, Brenner B, Moisi D, Detorio M, Cesaire R, Kurimura T, Mori H, Essex M, Maayan S, Wainberg MA. Turner D, et al. Antimicrob Agents Chemother. 2004 Aug;48(8):2993-8. doi: 10.1128/AAC.48.8.2993-2998.2004. Antimicrob Agents Chemother. 2004. PMID: 15273111 Free PMC article.

8

Resistance issues with new nucleoside/nucleotide backbone options.

Wainberg MA, Turner D. Wainberg MA, et al. Among authors: turner d. J Acquir Immune Defic Syndr. 2004 Sep 1;37 Suppl 1:S36-43. doi: 10.1097/01.qai.0000137005.63376.6e. J Acquir Immune Defic Syndr. 2004. PMID: 15319668

9

Variability in the PR and RT genes of HIV-1 isolated from recently infected subjects.

Turner D, Roldan A, Brenner B, Moisi D, Routy JP, Wainberg MA. Turner D, et al. Antivir Chem Chemother. 2004 Sep;15(5):255-9. doi: 10.1177/095632020401500504. Antivir Chem Chemother. 2004. PMID: 15535047 Free article. Review.

10

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection.

Turner D, Brenner B, Routy JP, Moisi D, Rosberger Z, Roger M, Wainberg MA. Turner D, et al. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1627-31. doi: 10.1097/00126334-200412150-00017. J Acquir Immune Defic Syndr. 2004. PMID: 15577421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,830 results

Search Page

Filters